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ABSTRACT
Objective: A growing body of research questions the reliance of 
symptom self-reports in the clinical evaluation of attention-deficit/
hyperactivity disorder (ADHD) in adulthood. A recent study suggested 
that also impairment reports are vulnerable to noncredible responses, 
as derived from a simulation design using a global functional 
impairment scale. The present study aims to add evidence to this 
issue, by using an ADHD specific impairment scale in a simulation 
design on large samples. Method: Impairment ratings on the Weiss 
Functional Impairment Rating Scale (WFIRS) of 62 patients with ADHD 
were compared to 142 healthy individuals who were instructed to 
show normal behavior. Furthermore, impairment ratings of patients 
with ADHD were compared to ratings of 330 healthy individuals who 
were randomly assigned to one of four simulation conditions that 
were instructed to complete the scale as if they had ADHD. Results: 
Patients with ADHD reported higher levels of impairment than the 
healthy control group in all domains of life. Furthermore, individuals 
instructed to feign ADHD indicated higher levels of impairments in 
most domains of life compared to control participants and genuine 
patients with ADHD. The group differences between individuals 
feigning ADHD and individuals with genuine ADHD, however, were 
only small to moderate. Further analyses revealed that the WFRIS was 
not useful to successfully differentiate genuine from feigned ADHD. 
Conclusions: The present study confirms the conclusion that self-
reported impairments are susceptible to noncredible responses and 
should be used with caution in the clinical evaluation of adult ADHD.
Patients’ self-reports represent an important and often the main source of information at 
diagnostic evaluation of attention-deficit/hyperactivity disorder (ADHD) in adulthood 
(American Psychiatric Association, 2013; Kooij et al., 2008). This is a major problem as ample 
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evidence exists that questions the reliability of self-reports, e.g. because a considerable 
number of individuals in the clinical evaluation of ADHD feign symptoms in order to get 
access to secondary benefits from a diagnosis of ADHD (Harrison, Edwards, & Parker, 2007; 
Suhr, Hammers, Dobbins-Buckland, Zimak, & Hughes, 2008). The problem of noncredible 
symptom report in the clinical evaluation of ADHD is emphasized by consistent findings 
showing that symptom self-report scales are unable to distinguish genuine patients with 
ADHD from individuals instructed to feign ADHD (Tucha, Fuermaier, Koerts, Groen, & Thome, 
2015).
In addition to the assessment of ADHD symptom severity, a comprehensive clinical eval-
uation and treatment planning also requires a proper assessment of impairments in various 
settings of life. However, while numerous studies demonstrated that self-reported symptoms 
are vulnerable to noncredible responses, the vulnerability of self-reported impairments 
remained unknown until a very recent study of Bryant and colleagues (2017). In this study, 
a simulation design was performed using the World Health Organization Disability 
Assessment Schedule 2.0 (WHODAS; World Health Organization, 2012). Healthy individuals 
instructed to feign ADHD reported higher levels of impairment than healthy control partic-
ipants and genuine patients with ADHD, leading the authors to conclude that the WHODAS 
impairment scale is susceptible to noncredible responses and should be used with caution 
at clinical evaluation of adult ADHD.
The present study aimed to add evidence to the susceptibility of impairment reports in 
the clinical evaluation of adults with ADHD. In this study, we did not use a global functional 
impairment scale, but instead a functional impairment scale that is widely used in clinical 
practice for the assessment of adults with ADHD, i.e. the Weiss Functional Impairment Rating 
Scale (WFIRS; Canadian ADHD Resource Alliance [CADDRA], 2017). The WFIRS has been spe-
cifically designed to measure impairment associated with ADHD in several domains and 
aspects of daily living, including family, work, self-concept, life skills, social functioning, and 
risk behavior. We conducted a large-scale simulation design with 472 healthy individuals 
who were assigned to either a control condition or to one of four simulation conditions and 
compared findings to a group of patients with ADHD.
Method
Participants
Sixty-two patients with ADHD participated in the study (Table 1). Patients were self-referred 
or referred from local psychiatrists or neurologists to the Department of Psychiatry and 
Psychotherapy of the SRH Clinic Karlsbad-Langensteinbach, Germany. A diagnostic assess-
ment for ADHD in adulthood as well as participation in the research project was offered to 
all participants. It was pointed out to patients with ADHD that the clinical evaluation and 
Table 1. Characteristics of participants.
note: Cg = Control group; aDhD = patients with aDhD; sg = simulation group.
CG ADHD SG
n 142 62 330
age (in years, M ± SD) 31.0 ± 12.3 36.2 ± 11.1 26.8 ± 10.0
gender (female/male) 66/76 26/36 189/141
education (in years, M ± SD) 14.0 ± 2.6 11.8 ± 3.3 16.0 ± 2.5
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the participation in the research project were separated from each other. Thus, the materials 
used for the research part (including the WFIRS) were not analyzed for the purpose of the 
clinical evaluation of individuals, but were analyzed anonymously and contributed to the 
research project only. Participation in the research study was separated from the clinical 
assessment and treatment in order to exclude possible incentives for individuals feigning 
ADHD to take part in the study.
Thirty-seven of the patients with ADHD met criteria for ADHD – combined type, 24 
patients met criteria for ADHD – predominantly inattentive type, and one patient met criteria 
for ADHD – hyperactive-impulsive type, as outlined in the Diagnostic and Statistical Manual 
of Mental Disorders (4th ed.; DSM-IV; American Psychiatric Association, 1994). Twenty-five 
of the 62 patients with ADHD were diagnosed with one or more comorbid disorders, includ-
ing mood disorders, anxiety disorder, personality disorders, and substance abuse disorders. 
Sixteen patients with ADHD were treated with antidepressant medication at the time of the 
study, whereas three patients with ADHD were currently treated with stimulant 
medication.
Furthermore, 472 healthy individuals participated in the study (Table 1). Healthy individ-
uals were recruited via public announcements, word-of-mouth and through contacts of the 
researchers involved. None of the healthy individuals reported to have a history of neuro-
logical or psychiatric disease and none were taking any medication known to affect the 
central nervous system. Furthermore, all healthy participants scored below the clinical cut-
offs of two standardized self-report rating scales for current and retrospective ADHD symp-
toms (Adler et al., 2006; Kessler et al., 2005; Ward, Wender, & Reimherr, 1993).
Materials
The Weiss Functional Impairment Rating Scale (WFIRS) is a self-report measure for impair-
ments that commonly occur in patients with ADHD and that are likely to represent the 
patients’ targets of treatment (CADDRA, 2017). The WFIRS comprises 70 items that are divided 
into seven domains: Family (8 items), Work (11 items), School (11 items), Life Skills (12 items), 
Self-concept (5 items), Social (9 items), and Risk (14 items). The domain School was not con-
sidered in the present study as the majority of individuals did not follow an educational 
training at the time of participation. Each item employs a four-point Likert scale scored from 
0 to 3 (0 = never, not at all; 1 = sometimes, somewhat; 2 = often, much; 3 = very often, very 
much). An additional option to answer is given with Not Applicable. A scale score per domain 
is calculated by summing up the responses to all items per domain (response values 0 
through 3), and dividing this sum by the number of endorsed items (thereby not considering 
items that are answered with Not Applicable). The WFIRS was reported to yield high internal 
consistency with Cronbach’s α > .8 for each domain and the scale as a whole. Furthermore, 
the WFIRS was reported to be sensitive to change with treatment and to correlate with 
change in ADHD symptoms and overall psychopathology (CADDRA, 2017).
In addition, three measures of performance validity were applied in order to ensure the 
credibility of patients with ADHD, i.e. the Test of Memory Malingering (TOMM; Tombaugh, 
1997), the Dot Counting Test (DCT; Boone, Lu, & Herzberg, 2002), and the Groningen Effort 
Test (GET; Fuermaier, Tucha, Koerts, Aschenbrenner, & Tucha, 2016; Fuermaier, Tucha, Koerts, 
Grabski, et al., 2016). Cut-offs were applied as suggested in the test manuals.
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Design and procedure
Participation in the research study was separated from diagnostic assessment of patients 
with ADHD. Diagnostic assessment for ADHD involved a clinical psychiatric interview accord-
ing to DSM-IV criteria and was supported by two standardized self-report rating scales 
designed to quantify current and retrospective ADHD symptoms (Adler et al., 2006; Kessler 
et al., 2005; Ward et al., 1993). Diagnostic veracity was corroborated by the identification of 
objective evidence of impairment (e.g. financial problems, failure in academic setting, losing 
jobs, drug use) and/or the consult of collateral information. The research study was per-
formed in the years from 2013 to 2016 and was conducted in compliance with ethical stand-
ards and was approved by local institutional ethical committees. Patients were only 
considered for inclusion in the study if they passed all effort tests that were presented to 
them. The completion of the WFIRS for patients with ADHD was part of a larger assessment 
which took about 2.5 h in total. Seventy-four patients with ADHD were initially considered 
for inclusion in the present study. Forty-eight patients with ADHD performed the TOMM and 
DCT, whereas the GET was presented to 26 patients with ADHD. Twelve patients with ADHD 
(16%) were not further considered as they failed the effort measures presented to them. The 
remaining 62 patients with ADHD were asked to fill out the WFIRS to the best of their knowl-
edge and not to seek help from the examiner or to discuss questions or their responses.
The assessment of healthy individuals took about 30–60 min, depending on the condition 
they were assigned to. All healthy participants completed a demographic questionnaire, 
two self-report rating scales for current and retrospective ADHD symptoms, as well as the 
WFIRS. Instruction how to complete the WFIRS differed between the conditions healthy 
individuals were assigned to. Two control groups were recruited; control group 1 (n = 67) 
was recruited in order to obtain a matched group to patients with ADHD with comparable 
characteristics in age, gender, and years of education. Control group 2 (n = 75) was obtained 
from the simulation design in which 405 healthy participants were randomly assigned to 
either the control group 2 (n = 75), or to one of four simulation conditions that varied by 
type and level of coaching. Participants of the control groups were asked to complete the 
WFIRS to the best of their knowledge. WFIRS scores of both control groups did not differ 
significantly, therefore control groups 1 and 2 were collapsed into one single control group 
(CG; n = 142) for further analyses. Participants of the simulation conditions were asked to 
complete the WFIRS while pretending to be affected by ADHD. Because simulation group 
differences were not the focus of this study, these four conditions were combined into one 
simulation group (SG: n = 330).
Statistical analysis
Because assumptions for parametric analyses were not met (e.g. normality, homogeneity of 
variances), nonparametric statistical analyses (Kruskal–Wallis tests) were calculated to com-
pare the groups on each domain of the WFIRS. Dunn’s tests were performed as post hoc 
multiple pairwise comparisons. Significance level was initially set to .05, but was Bonferroni 
corrected in order to control for alpha error growth in multiple testing (i.e. .05/6 = .008 to 
control for pairwise comparisons on each of the six domains of the WFIRS). Effect sizes 
(Cohen’s d) were calculated to indicate the magnitude of pairwise group differences. Effect 
sizes were interpreted based on Rogers’ classification into moderate effects (.75 ≤ d < 1.25), 
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large effects (1.25 ≤ d < 1.50), and very large effects (d ≥ 1.50) (Rogers, 2008). Furthermore, 
for those scales of the WFIRS that revealed significant differences between patients with 
ADHD and the simulation group, receiver operating characteristics (ROC) were calculated 
in order to explore the utility of the WFIRS in distinguishing patients with ADHD from indi-
viduals instructed to feign ADHD. Clinical utility was also examined by classification statistics 
of sensitivity, specificity, positive predictive value (ppv), and negative predictive value (npv).
Results
WFIRS scores of healthy control participants, patients with ADHD, and the simulation group 
are presented in Table 2. Nonparametric statistical analyses as presented in Table 2 revealed 
significant differences between the three groups in each domain of the WFIRS. Post-hoc 
multiple pairwise comparisons indicated that both patients with ADHD and the simulation 
group scored significantly higher on each scale of the WFIRS than the control group. 
Furthermore, the simulation group scored significantly higher than patients with ADHD in 
the domains Family, Work, Social, and Risk, whereas no significant differences were obtained 
in Life Skills and Self-concept. Effect sizes of group differences between patients with ADHD 
and the simulation group were negligible to moderate.
Finally, ROC analyses demonstrated that the scales Family, Work, Social, and Risk could 
distinguish significantly between feigned ADHD and genuine ADHD (all p-values ≤ .002); 
however, classification accuracies were only moderate as shown by area under the curves 
(AUCs) of 64.3% (Family), 71.4% (Work), 62.9% (Social), and 78.1% (Risk). A graphical illustra-
tion of diagnostic accuracies of the four scales of the WFIRS is presented in Figure 1. The 
limited clinical utility of the WFIRS in distinguishing genuine from feigned ADHD was also 
shown by classification statistics of sensitivity, specificity, ppv, and npv. Setting the cut-off 
on each scale to achieve desired specificity of 90% (Boone, 2007; Marshall et al., 2010) resulted 
in insufficient or only moderate classification accuracies of all scales (Table 3).
Discussion
As expected, patients with ADHD in the present study reported significantly higher levels 
of impairment than healthy control individuals in all domains of life. More importantly for 
the present context, instructed simulators reported significantly higher levels of impairment 
than control participants in each of the six domains, and higher levels of impairment than 
genuine patients with ADHD in four domains of life. However, effect sizes between genuine 
patients with ADHD and instructed simulators were only small to moderate, which implies 
that one might not be able to distinguish genuine from feigned ADHD based on individual 
impairment reports. This is also illustrated by ROC analyses which revealed that WFIRS scores 
were significantly predictive for feigned ADHD relative to genuine ADHD; however, diag-
nostic accuracies were only moderate (AUCs ranging from 62.9 to 78.1%) and question the 
clinical utility of the WFIRS for the detection of feigned ADHD.
The results of the present study confirm previous research showing that self-reported 
impairment scales are susceptible to noncredible responses in the clinical evaluation of adult 
ADHD and agree with the statement of Bryant and colleagues that ‘the assessment for the 
validity of self-report and performance should be included in all evaluations, including 
assessments for ADHD’ (Bryant et al., 2017; Heilbronner et al., 2009). The use of measures of 
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both performance and symptom validity appears particularly relevant given the findings of 
only weak associations between both types of measures in the clinical evaluation of adults 
with ADHD (Hirsch & Christiansen, 2015). With regard to patients’ self-reports, previous stud-
ies as well as the present data revealed an over-reporting response bias of noncredible 
individuals relative to genuine patients with ADHD (Fuermaier, Tucha, Koerts, Weisbrod, 
et al., 2016; Harrison & Armstrong, 2016; Suhr, Buelow, & Riddle, 2011). Clinicians aiming to 
assess symptom validity are therefore advised to make use of scales consisting of items that 
are infrequently endorsed by healthy individuals and genuine patients with ADHD, in order 
to successfully distinguish credible from noncredible individuals. While such scales are not 
ready for use in clinical practice, yet, promising work has been done in the development 
and validation of infrequency scales or exaggeration indices that consist of items that are 
embedded within valid and widely used self-report inventories, as this would make the 
detection strategy less obvious to individuals feigning the condition (Cook, Bolinger, & Suhr, 
2016; Harrison & Armstrong, 2016; Suhr et al., 2011).
Figure 1. receiver operating characteristic (roC) curves indicating diagnostic accuracies of four scales 
of the Weiss Functional impairment rating scale (WFirs) in identifying feigned aDhD (n = 330) relative 
to genuine aDhD (n = 62).
Table 3. Classification accuracies of four scales of the Weiss Functional impairment rating scale (WFirs) 
in identifying feigned aDhD (n = 330) relative to genuine aDhD (n = 62).
note: ppV = positive predictive value; npV = negative predictive value.
Domain Cutoff Specificity (%) Sensitivity (%) PPV (%) NPV (%)
Family 2.14 89.7 17.1 88.9 16.8
Work 2.29 89.7 13.5 88.0 19.3
social 2.12 89.7 13.8 88.2 16.4
risk 1.42 89.7 47.7 95.7 24.1
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Of note, effect sizes of group differences between patients with ADHD and instructed 
simulators in the present study were smaller compared to most of the effects reported by 
Bryant and colleagues (2017). This could be explained by the use of an ADHD-specific scale 
in the present study. It can be assumed that a disease-specific scale likely results in larger 
impairment scores of adults with ADHD, which may reduce the over-reporting effect of 
individuals instructed to feign ADHD relative to genuine ADHD patients. The use of an ADHD-
specific impairment scale could also account for the lack of significant group differences 
between patients with ADHD and instructed simulators on Self-concept, as patients with 
ADHD indicated marked impairments in this domain. The group of patients with ADHD had 
a mean score of 1.87 in this domain, while any score >1.5 is indicative for impairment 
(CADDRA, 2017). Furthermore, in contrast to the sample of patients included in the study of 
Bryant and colleagues (2017), the vast majority (about 95%) of patients with ADHD of the 
present study was not treated with stimulant medication. The early stage in the treatment 
process may have resulted in the endorsement of higher levels of impairment of patients 
with ADHD, which may have also reduced the over-reporting effect of individuals instructed 
to feign ADHD.
It must also be noted that the present study did not focus on student samples but included 
participants from the local community with regard to both the patient group and the exper-
imental groups of the simulation design. The present study therefore revealed that the find-
ings previously reported on student samples can be generalized to the non-academic 
setting.
Limitations
The present study must be seen in the context of some limitations. First, patients with ADHD 
of the present study were screened with one or two performance validity measures, and 
were included in the study only if they passed the measures presented to them. This may 
be problematic because this study focused on the credibility of self-reports of patients with 
ADHD, however, previous literature has shown that performance validity does not always 
translate into symptom validity (Hirsch & Christiansen, 2015). The inclusion of patients with 
ADHD that have been screened for both performance as well as symptom validity would 
strengthen the validity of the conclusions. In this context, it would also be interesting to 
include another clinical comparison group to the present study design, i.e. a group of patients 
with ADHD that failed measures of symptom and performance validity.
Furthermore, simulation designs in general can be criticized for a limited external validity, 
as the motive to feign ADHD in an experimental setting does not match real-life situations 
in clinical practice (Rogers, Harrell, & Liff, 1993). The validity of conclusions drawn from studies 
employing simulation designs would therefore benefit from studies using different research 
designs, such as known-groups comparisons.
Conclusion
The present study demonstrated that a widely used self-report scale assessing functional 
impairment of adults with ADHD is susceptible to noncredible self-reports. Clinicians should 
be prepared that over-reporting of symptoms and impairments may occur frequently in 
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clinical practice, and that the inclusion of proven measures assessing symptom and perfor-
mance validity in the clinical evaluation of adults with ADHD appears necessary.
Disclosure statement
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